Skip to main content

Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.

Publication ,  Journal Article
Holland, TL
Published in: Antimicrob Agents Chemother
June 23, 2020

Staphylococcus aureus bacteremia (SAB) is a complicated, high-risk disease. For selected low-risk SAB, the role of oral antibiotic stepdown therapy is unknown. Bupha-Intr et al. report a retrospective cohort of low-risk SAB patients who did well with a short duration of intravenous antibiotics, followed by an additional ∼10 days of oral antibiotics, primarily using beta-lactams. Prospective trials will help further define the efficacy of this approach.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Antimicrob Agents Chemother

DOI

EISSN

1098-6596

Publication Date

June 23, 2020

Volume

64

Issue

7

Location

United States

Related Subject Headings

  • beta-Lactams
  • Staphylococcus aureus
  • Staphylococcal Infections
  • Retrospective Studies
  • Prospective Studies
  • Microbiology
  • Humans
  • Bacteremia
  • Anti-Bacterial Agents
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Holland, T. L. (2020). Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen. Antimicrob Agents Chemother, 64(7). https://doi.org/10.1128/AAC.00317-20
Holland, Thomas L. “Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.Antimicrob Agents Chemother 64, no. 7 (June 23, 2020). https://doi.org/10.1128/AAC.00317-20.
Holland, Thomas L. “Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.Antimicrob Agents Chemother, vol. 64, no. 7, June 2020. Pubmed, doi:10.1128/AAC.00317-20.

Published In

Antimicrob Agents Chemother

DOI

EISSN

1098-6596

Publication Date

June 23, 2020

Volume

64

Issue

7

Location

United States

Related Subject Headings

  • beta-Lactams
  • Staphylococcus aureus
  • Staphylococcal Infections
  • Retrospective Studies
  • Prospective Studies
  • Microbiology
  • Humans
  • Bacteremia
  • Anti-Bacterial Agents
  • 3214 Pharmacology and pharmaceutical sciences